NEW YORK ( TheStreet) -- Shares of Obagi Medical Products (Nasdaq: OMPI) were gapping up Thursday morning with an open price 14.6% higher than Wednesday's closing price. The stock closed at $9.16 Wednesday and opened today's trading at $10.50. The average volume for Obagi Medical has been 64,300 shares per day over the past 30 days. Obagi Medical has a market cap of $180.8 million and is part of the health care sector and drugs industry. Shares are down 20.7% year to date as of the close of trading on Wednesday. Obagi Medical Products, Inc., a specialty pharmaceutical company, develops and markets topical aesthetic and therapeutic prescription skin care systems. The company has a P/E ratio of 40.5, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7. TheStreet Ratings rates Obagi Medical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. You can view the full Obagi Medical Ratings Report. Get more investment ideas from our investment research center. Interested in other stocks that are gapping up? Get free SMS text alerts sent to you when the action happens by texting UP to 95370 or select from multiple alert options.